Stock Events

Stock Events

Galderma Group 

$39.87
44
+$0.84+2.15% Tuesday 20:00
-$0.06-0.15%Tuesday 20:00After hours

Statistics

Day High
40.59
Day Low
39.81
52W High
46.31
52W Low
33.13
Volume
69,359
Avg. Volume
131,134
Mkt Cap
9.35B
P/E Ratio
53.47
Dividend Yield
0.17%
Dividend
0.07

Upcoming

Dividends

0.17%Dividend Yield
May 26
$0.07
May 25
$0.02
May 25
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
316.45%

Earnings

23JulExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0.88
1.37
1.85
2.34
Expected EPS
2.25
Actual EPS
2.34

Financials

11.77%Profit Margin
Profitable
2023
2024
2025
5.21BRevenue
613MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GALDY. It's not an investment recommendation.
Nestle SA
14
NESN.SW
Amazon
12
AMZN
Novartis
12
NOVN.SW
Zurich Insurance Group
12
ZURN.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson offers a wide range of skincare products through its consumer health division, directly competing with Galderma's offerings in the dermatological care market.
Novartis
NVS
Mkt Cap304.1B
Novartis, former parent company of Galderma, has a strong presence in the healthcare sector, including dermatology, competing in therapeutic areas similar to Galderma.
Pfizer
PFE
Mkt Cap162.16B
Pfizer competes in the pharmaceuticals sector including dermatology, offering products that overlap with Galderma’s therapeutic solutions.
Merck
MRK
Mkt Cap370.89B
Merck operates in the healthcare and pharmaceutical sectors with products that compete in dermatological conditions, a key area for Galderma.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol-Myers Squibb competes in various therapeutic areas including those that overlap with Galderma’s dermatology-focused portfolio.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly competes in the pharmaceutical field with a focus on medical dermatology, offering treatments that can compete with Galderma’s products.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline has a diversified healthcare portfolio that includes skin health products, competing with Galderma in the dermatology market.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca operates broadly in the pharmaceutical sector, including areas that compete with Galderma’s dermatological treatments.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals focuses on innovative treatments, including for skin diseases, which puts it in competition with Galderma’s dermatology products.

About

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Show more...
CEO
Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
Country
United States
ISIN
US36321W1053
WKN
000A40C38

Listings

MX
MX
GALDN.MX
F
DE
PY3.F
MU
DE
PY3.MU
STU
DE
PY3.STU

0 Comments

Share your thoughts

FAQ

What is Galderma Group stock price today?▼
The current price of GALDY is $39.87 USD — it has increased by +2.15% in the past 24 hours. Watch Galderma Group stock price performance more closely on the chart.
What is Galderma Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Galderma Group stocks are traded under the ticker GALDY.
Is Galderma Group stock price growing?▼
GALDY stock has fallen by -2.28% compared to the previous week, the month change is a -11.28% fall, over the last year Galderma Group has showed a +9.5% increase.
What is Galderma Group market cap?▼
Today Galderma Group has the market capitalization of 9.35B
When is the next Galderma Group earnings date?▼
Galderma Group is going to release the next earnings report on March 11, 2027.
What were Galderma Group earnings last quarter?▼
GALDY earnings for the last quarter are 2.34 USD per share, whereas the estimation was 2.25 USD resulting in a +4% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Galderma Group revenue for the last year?▼
Galderma Group revenue for the last year amounts to 5.21B USD.
What is Galderma Group net income for the last year?▼
GALDY net income for the last year is 613M USD.
Does Galderma Group pay dividends?▼
Yes, GALDY dividends are paid annual. The last dividend per share was 0.07 USD. As of today, Dividend Yield (FWD)% is 0.17%.
In which sector is Galderma Group located?▼
Galderma Group operates in the Other sector.
When did Galderma Group complete a stock split?▼
Galderma Group has not had any recent stock splits.
Where is Galderma Group headquartered?▼
Galderma Group is headquartered in Zug, United States.